The groundbreaking approach of the medication represents a exciting advance in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide166227.blogoscience.com/48762027/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment